137 related articles for article (PubMed ID: 37218550)
1. Serial virus filtration: A case study evaluating the product-dependent impact of control strategies on process efficiency.
Kozaili J; Shah A; Robbins D; Brinkman N; Burdick M; Strauss D
Biotechnol J; 2023 Sep; 18(9):e2200599. PubMed ID: 37218550
[TBL] [Abstract][Full Text] [Related]
2. Achieving a Successful Scale-Down Model and Optimized Economics through Parvovirus Filter Validation using Purified TrueSpikeTM Viruses.
De Vilmorin P; Slocum A; Jaber T; Schaefer O; Ruppach H; Genest P
PDA J Pharm Sci Technol; 2015; 69(3):440-9. PubMed ID: 26048749
[TBL] [Abstract][Full Text] [Related]
3. Use of MMV as a Single Worst-Case Model Virus in Viral Filter Validation Studies.
Gefroh E; Dehghani H; McClure M; Connell-Crowley L; Vedantham G
PDA J Pharm Sci Technol; 2014; 68(3):297-311. PubMed ID: 25188350
[TBL] [Abstract][Full Text] [Related]
4. Limits in virus filtration capability? Impact of virus quality and spike level on virus removal with xenotropic murine leukemia virus.
Roush DJ; Myrold A; Burnham MS; And JV; Hughes JV
Biotechnol Prog; 2015; 31(1):135-44. PubMed ID: 25395156
[TBL] [Abstract][Full Text] [Related]
5. Microscopic visualization of virus removal by dedicated filters used in biopharmaceutical processing: Impact of membrane structure and localization of captured virus particles.
Adan-Kubo J; Tsujikawa M; Takahashi K; Hongo-Hirasaki T; Sakai K
Biotechnol Prog; 2019 Nov; 35(6):e2875. PubMed ID: 31228338
[TBL] [Abstract][Full Text] [Related]
6. The evolution of down-scale virus filtration equipment for virus clearance studies.
Wieser A; Berting A; Medek C; Poelsler G; Kreil TR
Biotechnol Bioeng; 2015 Mar; 112(3):633-7. PubMed ID: 25220795
[TBL] [Abstract][Full Text] [Related]
7. Viral clearance in end-to-end integrated continuous process for mAb purification: Total flow-through integrated polishing on two columns connected to virus filtration.
Shirataki H; Matsumoto Y; Konoike F; Yamamoto S
Biotechnol Bioeng; 2023 Oct; 120(10):2977-2988. PubMed ID: 37288613
[TBL] [Abstract][Full Text] [Related]
8. Implementation of a 20-nm pore-size filter in the plasma-derived factor VIII manufacturing process.
Furuya K; Murai K; Yokoyama T; Maeno H; Takeda Y; Murozuka T; Wakisaka A; Tanifuji M; Tomono T
Vox Sang; 2006 Aug; 91(2):119-25. PubMed ID: 16907872
[TBL] [Abstract][Full Text] [Related]
9. Virus filter scalability: Demonstration of consistent viral clearance across laboratory and manufacturing scales.
Buesing B; Schwartz A; Shah A; Sohka T; Hirotomi N; Strauss D
Biologicals; 2021 Jul; 72():27-32. PubMed ID: 34226123
[TBL] [Abstract][Full Text] [Related]
10. Twenty plus Years of Data Demonstrating Virus Filtration as an Effective and Robust Step for Large Virus Removal.
Stanley B; Holmes V; Manzari R; Romanowski C; Tessarz A; Ruppach H; Schreffler J
PDA J Pharm Sci Technol; 2022; 76(1):1-8. PubMed ID: 33990425
[TBL] [Abstract][Full Text] [Related]
11. Adapting virus filtration to enable intensified and continuous monoclonal antibody processing.
Bohonak DM; Mehta U; Weiss ER; Voyta G
Biotechnol Prog; 2021 Mar; 37(2):e3088. PubMed ID: 33016523
[TBL] [Abstract][Full Text] [Related]
12. Adapting virus filtration to continuous processing: Effects of product and process variability on filtration performance.
Kozaili J; Rayfield W; Gospodarek A; Brower M; Strauss D
Biotechnol Prog; 2024; 40(2):e3407. PubMed ID: 38146086
[TBL] [Abstract][Full Text] [Related]
13. The Use of Bayesian Hierarchical Logistic Regression in the Development of a Modular Viral Inactivation Claim.
Banton D; Vacante D; Bulthuis B; Goldstein J; Wineburg M; Schreffler J
PDA J Pharm Sci Technol; 2019; 73(6):552-561. PubMed ID: 31101710
[TBL] [Abstract][Full Text] [Related]
14. Meeting report--workshop on virus removal by filtration: trends and new developments.
Willkommen H; Blümel J; Brorson K; Chen D; Chen Q; Gröner A; Kreil TR; Robertson JS; Ruffing M; Ruiz S
PDA J Pharm Sci Technol; 2013; 67(2):98-104. PubMed ID: 23569071
[TBL] [Abstract][Full Text] [Related]
15. Multi-round virus filter integrity test sensitivity.
Dowd CJ
Biotechnol Bioeng; 2009 Jun; 103(3):574-81. PubMed ID: 19253932
[TBL] [Abstract][Full Text] [Related]
16. Virus filtration: A review of current and future practices in bioprocessing.
Johnson SA; Chen S; Bolton G; Chen Q; Lute S; Fisher J; Brorson K
Biotechnol Bioeng; 2022 Mar; 119(3):743-761. PubMed ID: 34936091
[TBL] [Abstract][Full Text] [Related]
17. Biopharmaceutical Industry Approaches to Facility Segregation for Viral Safety: An Effort from the Consortium on Adventitious Agent Contamination in Biomanufacturing.
Barone PW; Avgerinos S; Ballard R; Brussel A; Clark P; Dowd C; Gerentes L; Hart I; Keumurian FJ; Kindermann J; Leung JC; Ly N; Mink S; Minning S; Mullberg J; Murphy M; Nöske K; Parriott S; Shum B; Wiebe ME; Springs SL
PDA J Pharm Sci Technol; 2019; 73(2):191-203. PubMed ID: 30361281
[TBL] [Abstract][Full Text] [Related]
18. Protection of biomanufacturing processes from virus contamination through upstream virus filtration of cell culture media.
Wieser A; Modrof J; Kreil TR
Biotechnol Bioeng; 2023 Oct; 120(10):2917-2924. PubMed ID: 37337932
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Effect of the Volume Throughput and Maximum Flux of Low-Surface-Tension Fluids on Bacterial Penetration of 0.2 Micron-Rated Filters during Process-Specific Filter Validation Testing.
Folmsbee M
PDA J Pharm Sci Technol; 2015; 69(2):307-16. PubMed ID: 25868996
[TBL] [Abstract][Full Text] [Related]
20. RUNspike, a complementary virus filter spiking method: a solution to the problem of reduced throughput due to the addition of the virus spike.
Parrella J; Wu Y; Kahn DW; Genest P
PDA J Pharm Sci Technol; 2009; 63(6):547-58. PubMed ID: 20169861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
